The Effects of Gaviscon and Metoclopramide in Gastroesophageal Reflux in Children


    loading  Checking for direct PDF access through Ovid

Abstract

SummaryOral metoclopramide (0.5 mg/kg/24 h) and a liquid alginic acid-antacid compound were administered to infants and children with gastroesophageal reflux (GER) in a double-blind randomized controlled trial. The effect of medication was measured with 24-h intraesophageal pH monitoring. Neither metoclopramide nor the alginic acid-antacid compound decreased the frequency or duration of gastroesophageal reflux.

    loading  Loading Related Articles